Imprint

Dr. Roland Alexander, MBA
Manager
r.alexander(at)lifescienceslink.org

Monika Flögel
Information Desk
m.floegel(at)lifescienceslink.org

Herbert-Worch-Stiftung
Kaiserplatz 10
53113 Bonn
Germany

Phone:	+ 49 - 228 - 249843
Fax:	+ 49 - 228 - 2498448

latest entries

Antioxidant substance fractions for cosmetic formulations
polyphenolic ingredients from Rheum
NMDA Antagonists - New selective compounds to the NR2B subunit with high affinity
novel derivatives of benzofused nitrogen heterocycles as selective antagonists of the NR2B subunit of the NMDA-receptor
NuPathe is looking for neuroscience products with preclinical or clinical proof-of-concept and CNS drug delivery technologies
Novo Nordisk is actively searching for collaboration opportunities within Diabetes and Protein Technologies, Inflammation, Hemophilia and Protein Delivery Devices
Diabetes, Protein Technologies, Inflammation, Hemophilia, Protein Delivery Devices, GLP-1 receptor, hypoglycemia, Insulin resistance, Obesity, Cytokines
Modulating the Transport of Thiol-Containing Molecules for the Treatment of Lung Disease and Cancer
compounds increase endogenous glutathione in the epithelial lining fluid and therefore could decrease oxidative damage in these diseases

© 2006-2007
by Herbert-Worch-Foundation